featured
Real-World Study of SGLT2 Inhibitors in Patients With Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-world Evidence of Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience
Diabetes Care 2022 Jan 21;[EPub Ahead of Print], A Palanca, F van Nes, F Pardo, FJ Ampudia Blasco, C MathieuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.